Squarepoint Ops LLC Bio Atla, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.37 - $3.92 $96,720 - $276,748	70,599 New	70,599 $96,000
Q1 2023 May 15, 2023	BUY	$2.3 - $8.25 $9,758 - $35,004	4,243 Added 28.41%	19,179 $51,000
Q4 2022 Feb 14, 2023	BUY	$6.29 - $11.01 $93,947 - $164,445	14,936 New	14,936 $123,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $5.38 $149,532 - $377,692	-70,203 Reduced 66.81%	34,882 $99,000
Q1 2022 May 16, 2022	BUY	$4.38 - $18.78 $386,399 - $1.66 Million	88,219 Added 523.06%	105,085 $525,000
Q4 2021 Feb 14, 2022	BUY	$19.0 - $30.95 $320,454 - $522,002	16,866 New	16,866 $331,000
Q3 2021 Nov 15, 2021	SELL	$29.44 - $43.74 $233,164 - $346,420	-7,920 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.07 - $56.17 $301,514 - $444,866	7,920 New	7,920 $336,000

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.